BRNS
Barinthus Biotherapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$0.76
+5.50%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-73.1%
Return on equity
-51.0%
Return on assets
-66.2%
Return on invested capital
0.00x
Asset turnover
-$26.4M
Cash from operations
$1.45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026